Fatty acids provide essential fuel and membrane building blocks, but in excess they act as detergents that disrupt cellular membranes and organization. Ceramides evolved as a solution to this problem, stabilizing lipid membranes while serving as sensors of fatty acid excess. As ceramides accrue, they shift fatty acids out of vulnerable membrane pools and into oxidation or storage, while redirecting cellular metabolism to accommodate the lipid surplus. These actions define the first phase of lipotoxicity, which buffers fatty acid excess but produces reversible metabolic abnormalities, including impaired glucose utilization, diminished mitochondrial efficiency, and enhanced lipid storage. When ceramide levels exceed a critical threshold, they promote mitochondrial failure, fibrosis, and cell death. This second phase initially limits further damage by eliminating irreparably stressed cells, but at the cost of irreversible injury in the liver, heart, kidney, pancreas, and vasculature. The presentation will examine the evolutionary logic of ceramide biology and discuss therapeutic strategies that neutralize ceramide toxicity before metabolic dysfunction progresses to end-organ disease.